Direct-acting antiviral treatment for hepatitis C, reinfection and mortality among people attending an inner-city community health centre in Victoria, Canada
- 1 October 2019
- journal article
- research article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 72, 106-113
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic reviewThe Lancet Global Health, 2017
- Hepatitis C point-of-care diagnostics: in search of a single visit diagnosisExpert Review of Molecular Diagnostics, 2017
- Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment programJournal of Substance Abuse Treatment, 2017
- Clinicians' Views of Hepatitis C Virus Treatment Candidacy With Direct-Acting Antiviral Regimens for People Who Inject DrugsSubstance Use & Misuse, 2016
- Recommendations for the management of hepatitis C virus infection among people who inject drugsInternational Journal of Drug Policy, 2015
- Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, CanadaDrug and Alcohol Dependence, 2015
- Trends in mortality after diagnosis of hepatitis C virus infection: An international comparison and implications for monitoring the population impact of treatmentJournal of Hepatology, 2015
- Treatment of Hepatitis C Virus Infection Among People Who Are Actively Injecting Drugs: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2013
- Models of Care for the Management of Hepatitis C Virus Among People Who Inject Drugs: One Size Does Not Fit AllClinical Infectious Diseases, 2013
- Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis CGastroenterology, 2005